Aquestive Therapeutics, Inc. Income Taxes Paid
Aquestive Therapeutics, Inc. (AQST) reported Income Taxes Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-03-04
- Aquestive Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $0.00.
- Aquestive Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- Aquestive Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-06-30 was -$1.52M.
- Aquestive Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-03-31 was $1.52M, a 52.04% increase year-over-year.
- Aquestive Therapeutics, Inc. income taxes paid, net for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Aquestive Therapeutics, Inc. income taxes paid, net for fiscal 2024 was $305.00K.
- Aquestive Therapeutics, Inc. income taxes paid, net for fiscal 2023 was $0.00.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | -$1.52M derived: sum of 3 quarters · filed 2026-03-04 | $0.00 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.52M derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $0.00 derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-03-31 | $1.52M 10-Q · filed 2025-05-12 | $1.52M derived: sum of 2 quarters · filed 2026-03-04 | $1.52M derived: sum of 3 quarters · filed 2026-03-04 | $827.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | -$698.00K derived: sum of 3 quarters · filed 2026-03-04 | $305.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$698.00K derived: sum of 2 quarters · filed 2025-11-05 | $305.00K 10-Q · filed 2025-11-05 | $305.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$698.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $305.00K 10-Q · filed 2025-08-11 | $305.00K derived: sum of 3 quarters · filed 2025-08-11 | $305.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-12 | $1.00M derived: sum of 2 quarters · filed 2025-05-12 | $1.00M derived: sum of 3 quarters · filed 2025-05-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 derived: sum of 2 quarters · filed 2025-03-05 | $0.00 10-K · filed 2025-03-05 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |